Palefsky, Joel M <br/><br/>
A trial of SGN-00101 (HspE7) to treat high-grade anal intraepithelial neoplasia in HIV-positive individuals.  [electronic resource] 

 -  AIDS (London, England)  May 2006 
 - 1151-5 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>0269-9370 
<br/><br/><label>Standard No.: </label>10.1097/01.aids.0000226955.02719.26  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Anus Neoplasms--immunology<br/>Bacterial Proteins--immunology<br/>CD4 Lymphocyte Count<br/>CD8-Positive T-Lymphocytes--immunology<br/>Cancer Vaccines--therapeutic use<br/>Carcinoma in Situ--immunology<br/>Chaperonin 60<br/>Chaperonins--immunology<br/>Dose-Response Relationship, Immunologic<br/>Female<br/>HIV Seropositivity--complications<br/>HIV-1--isolation & purification<br/>Human papillomavirus 16--immunology<br/>Humans<br/>Lymphocyte Count<br/>Male<br/>Middle Aged<br/>Papillomaviridae--isolation & purification<br/>Papillomavirus E7 Proteins--immunology<br/>Papillomavirus Infections--complications<br/>Recombinant Fusion Proteins<br/>Vaccination--methods<br/>Viral Load<br/>Viral Vaccines--therapeutic use